mitogen-activated protein kinase kinase 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| MAPK cascade | ||
| JNK cascade | ||
| heart development | ||
| positive regulation of gene expression | ||
| Schwann cell development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| perinuclear region of cytoplasm |
| GO Term | Evidence Code | PMID |
|---|---|---|
| MAP-kinase scaffold activity | ||
| protein binding | ||
| ATP binding | ||
| JUN kinase kinase activity | ||
| PDZ domain binding |
| Gene Ontology |
|---|
| ATP binding |
| MAP kinase kinase activity |
| kinase activity |
| nucleotide binding |
| phosphorylation |
| transferase activity |
| InterPro |
|---|
| Protein kinase domain |
| Protein kinase, ATP binding site |
| Protein kinase-like domain superfamily |
| Serine/threonine-protein kinase, active site |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111463 | cardiofaciocutaneous syndrome 4 | |
| DOID:4906 | small intestine adenocarcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026